 Levels endothelin bronchoalveolar lavage fluid patients symptomatic asthma reversible airflow obstruction human bronchial smooth muscle cells single class specific sites potent bronchoconstrictive peptide human bronchial epithelial cells endothelin-like material culture muscle cell receptors kinetic analogous authentic peptide potential role endothelin pathogenesis asthma study release endothelin airways patients asthma time symptomatic reversible airflow obstruction remission phase disease treatment normal volunteers patients chronic bronchitis airflow obstruction bronchodilators control subjects release endothelin airway mucosa RIA bronchoalveolar lavage fluid bronchoscopy Patients asthma amounts immunoreactive endothelin bronchoalveolar lavage fluid normal control chronic bronchitis absence significant alteration levels peptide Treatment patients asthma oral corticosteroids beta-agonists days improvement airflow obstruction threefold reduction contents endothelin lavage fluid findings potent bronchoconstrictive substance endothelin pathogenesis airflow obstruction asthma